GleamWall
中文EN

RPID RAPID MICRO BIOSYSTEMS, INC.

Laboratory Analytical Instruments · Nasdaq · SEC CIK 1380106 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY20.8%
TTM net income YoY-15.1%
TTM EPS YoY-6.0%
Revenue 3-yr CAGR21.5%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-133.0%
Net margin-138.2%
FCF margin-121.7%
EBITDA margin-125.3%

Returns

ROE-191.8%
ROA-77.2%
ROIC (approx.)-118.5%
Asset turnover0.56x

Leverage & solvency

Liabilities / assets81.5%
Debt / equity2.18x
Current ratio2.20x
Interest coverage-18.93x

Cash quality & payout

Operating cash flow / net income0.87x
Accruals ratio-9.7%
Payout ratio—
Capex / revenue0.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$9.53M$8.05M$8.00M$11.28M$7.84M$7.26M$7.21M$8.22M
Cost of revenue$7.13M$6.84M$7.63M—$7.14M$6.99M$6.80M—
Gross profit$2.40M$1.21M$371,000—$696,000$275,000$404,000—
R&D expense$2.97M$3.33M$3.36M$3.22M$3.53M$3.23M$3.62M$3.40M
SG&A expense$6.33M$6.77M$7.44M$5.34M$5.64M$6.08M$5.69M$4.83M
Operating income-$10.64M-$12.32M-$13.85M-$12.21M-$11.37M-$12.15M-$11.66M-$10.23M
Interest expense$632,000$646,000$639,000$673,000$393,000$12,000$12,000$12,000
Income tax$21,000$45,000$8,000$14,000$8,000$11,000$7,000-$9,000
Net income-$11.27M-$12.92M-$14.28M-$12.50M-$11.51M-$11.86M-$11.26M-$9.67M
EBITDA-$9.99M-$11.65M-$13.15M-$11.42M-$10.57M-$11.34M-$10.81M-$9.36M
EPS (basic)-0.23-0.27-0.31—-0.26-0.27-0.26—
EPS (diluted)-0.23-0.27-0.31—-0.26-0.27-0.26—
Weighted avg. shares (diluted)48.88M48.35M45.43M—44.96M44.65M43.99M—
Balance sheet
Cash & equivalents$6.62M$14.69M$13.81M$20.03M$19.23M$18.62M$19.27M$17.28M
Short-term investments$102,000$5.08M$9.13M$18.27M$22.30M$12.92M$22.76M$33.82M
Receivables$7.67M$5.51M$6.37M$3.13M$5.43M$6.05M$4.52M$7.52M
Inventory$19.66M$18.92M$17.45M$17.59M$21.07M$20.56M$20.72M$20.20M
Current assets$36.32M$46.26M$49.23M$61.17M$69.95M$60.15M$69.18M$80.92M
PP&E, net$7.55M$8.16M$8.77M$8.97M$9.58M$10.21M$10.56M$11.19M
Total assets$47.57M$58.45M$62.36M$74.85M$84.41M$75.59M$85.43M$98.17M
Current liabilities$16.51M$18.15M$19.12M$18.49M$16.55M$16.40M$15.00M$17.57M
Long-term debt$19.22M$19.14M$19.05M$18.90M$18.83M——$0
Total debt$19.22M$19.14M$19.05M$18.90M$18.83M——$0
Total liabilities$38.76M$40.70M$41.97M$41.65M$40.08M$21.04M$19.94M$22.82M
Shareholders' equity$8.81M$17.75M$20.40M$33.21M$44.33M$54.55M$65.49M$75.35M
Net debt$12.60M$4.45M$5.24M-$1.13M-$402,000——-$17.28M
Cash flow statement
Operating cash flow-$13.56M-$12.70M-$15.06M-$3.25M-$9.05M-$9.70M-$9.06M-$9.91M
Capital expenditure$50,000-$223,000$394,000$92,000$73,000$366,000$319,000$98,000
Free cash flow-$13.61M-$12.48M-$15.45M-$3.34M-$9.12M-$10.07M-$9.38M-$10.01M
Investing cash flow$4.86M$4.22M$8.60M$3.89M-$9.58M$9.34M$10.68M$4.86M
Financing cash flow$625,000$9.35M$247,000$443,000$19.25M-$298,000$379,000-$6,000
Depreciation & amortization$647,000$674,000$706,000$790,000$804,000$811,000$847,000$869,000
Stock-based compensation$1.33M$1.32M$1.22M$627,000$1.15M$1.22M$1.04M$689,000

Free plan shows the latest 8 periods; Pro shows all 27 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.